Metacognitive training for psychosis (MCT): past, present, and future
Standard
Metacognitive training for psychosis (MCT): past, present, and future. / Moritz, Steffen; Menon, Mahesh; Balzan, Ryan; Woodward, Todd S.
in: EUR ARCH PSY CLIN N, Jahrgang 273, Nr. 4, 06.2023, S. 811-817.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Metacognitive training for psychosis (MCT): past, present, and future
AU - Moritz, Steffen
AU - Menon, Mahesh
AU - Balzan, Ryan
AU - Woodward, Todd S
N1 - © 2022. The Author(s).
PY - 2023/6
Y1 - 2023/6
N2 - This article provides an overview and retrospective on metacognitive training for psychosis (MCT), which first appeared approximately 2 decades ago. We recount how our empirical understanding of psychosis at that time led to the first preliminary version of the program. We describe setbacks and challenges that led to major changes, including revisions to existing modules (e.g., more focus on metacognitive variables, particularly on decision confidence as one of the primary targets of treatment) and the creation of new modules addressing mood, as well as attempts to improve sustainability of effects via homework exercises and a smartphone app ( www.uke.de/mct_app ). We have also enhanced dissemination efforts by creating new culturally sensitive language versions and facilitating low-threshold training through e-learning courses ( www.uke.de/e-mct ). Finally, we discuss several meta-analyses on the efficacy of MCT that have been published over the last decade. While reviews were initially inconsistent, possibly reflecting the insufficient statistical power and lower design quality of the first MCT studies, more recent meta-analyses have confirmed the efficacy of MCT on positive symptoms, insight, and cognitive biases, which has led to the inclusion of MCT in some national treatment guidelines for schizophrenia.
AB - This article provides an overview and retrospective on metacognitive training for psychosis (MCT), which first appeared approximately 2 decades ago. We recount how our empirical understanding of psychosis at that time led to the first preliminary version of the program. We describe setbacks and challenges that led to major changes, including revisions to existing modules (e.g., more focus on metacognitive variables, particularly on decision confidence as one of the primary targets of treatment) and the creation of new modules addressing mood, as well as attempts to improve sustainability of effects via homework exercises and a smartphone app ( www.uke.de/mct_app ). We have also enhanced dissemination efforts by creating new culturally sensitive language versions and facilitating low-threshold training through e-learning courses ( www.uke.de/e-mct ). Finally, we discuss several meta-analyses on the efficacy of MCT that have been published over the last decade. While reviews were initially inconsistent, possibly reflecting the insufficient statistical power and lower design quality of the first MCT studies, more recent meta-analyses have confirmed the efficacy of MCT on positive symptoms, insight, and cognitive biases, which has led to the inclusion of MCT in some national treatment guidelines for schizophrenia.
KW - Humans
KW - Retrospective Studies
KW - Cognitive Behavioral Therapy
KW - Psychotic Disorders/therapy
KW - Schizophrenia/therapy
KW - Metacognition
KW - Treatment Outcome
U2 - 10.1007/s00406-022-01394-9
DO - 10.1007/s00406-022-01394-9
M3 - SCORING: Review article
C2 - 35338378
VL - 273
SP - 811
EP - 817
JO - EUR ARCH PSY CLIN N
JF - EUR ARCH PSY CLIN N
SN - 0940-1334
IS - 4
ER -